Role of Gut Microbiota in Overweight Susceptibility in an Adult Population in Italy.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
21 Jun 2023
Historique:
received: 30 05 2023
revised: 15 06 2023
accepted: 19 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Although the gut microbiota is known to affect body weight, its relationship with overweight/obesity is unclear. Our aim was to characterize microbiota composition in a cohort from the southernmost area of Italy. We investigated whether an altered gut microbiota could play an etiological role in the pathogenesis of overweight/obesity. A total of 163 healthy adults were enrolled. Microbiome analysis was performed via 16S rRNA gene sequencing. We found significant phylum variations between overweight (N = 88) and normal-weight (N = 75) subjects.

Identifiants

pubmed: 37447161
pii: nu15132834
doi: 10.3390/nu15132834
pmc: PMC10343630
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : "Ministry of Enterprises and Made in Italy" (MIMIT, ex MISE)
ID : F/190019/01/X44 CUP B71B20000690005

Références

Am J Clin Nutr. 2008 Oct;88(4):894-9
pubmed: 18842773
Diabetes. 2017 May;66(5):1405-1418
pubmed: 28223285
Gastroenterology. 2012 Oct;143(4):913-6.e7
pubmed: 22728514
Front Endocrinol (Lausanne). 2022 Oct 20;13:1025706
pubmed: 36339448
Obesity (Silver Spring). 2010 Jan;18(1):190-5
pubmed: 19498350
Am J Clin Nutr. 2017 Jan;105(1):3-4
pubmed: 28003208
BMC Microbiol. 2017 May 22;17(1):120
pubmed: 28532414
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070-5
pubmed: 16033867
Proc Nutr Soc. 2015 Aug;74(3):227-34
pubmed: 25518735
Therap Adv Gastroenterol. 2013 Jul;6(4):295-308
pubmed: 23814609
PLoS One. 2016 May 26;11(5):e0154090
pubmed: 27228093
Front Pharmacol. 2019 Nov 15;10:1366
pubmed: 31803056
World J Gastroenterol. 2015 Aug 7;21(29):8787-803
pubmed: 26269668
Diseases. 2022 Dec 29;11(1):
pubmed: 36648872
Nephrol Dial Transplant. 2019 May 1;34(5):783-794
pubmed: 30085297
Lipids Health Dis. 2016 Jun 18;15:108
pubmed: 27317359
Nutrients. 2020 Jul 21;12(7):
pubmed: 32708278
PLoS One. 2015 Apr 15;10(4):e0124599
pubmed: 25874569
Cell Host Microbe. 2012 Nov 15;12(5):611-22
pubmed: 23159051
Braz J Microbiol. 2015 Oct-Dec;46(4):1141-5
pubmed: 26691473
BMC Microbiol. 2020 Jul 22;20(1):221
pubmed: 32698765
J Pers Med. 2020 Dec 25;11(1):
pubmed: 33375615
mBio. 2016 Aug 23;7(4):
pubmed: 27555308
PLoS One. 2018 Dec 20;13(12):e0209209
pubmed: 30571698
Microorganisms. 2020 Nov 01;8(11):
pubmed: 33139627
Microorganisms. 2019 Jan 10;7(1):
pubmed: 30634578
Sci Rep. 2021 Mar 9;11(1):5532
pubmed: 33750881
Sci Rep. 2022 Mar 10;12(1):3952
pubmed: 35273317
Nutrients. 2020 May 19;12(5):
pubmed: 32438689
Nutrients. 2022 May 18;14(10):
pubmed: 35631244
Sci Rep. 2022 Feb 24;12(1):3140
pubmed: 35210542
Front Microbiol. 2017 Jun 30;8:1221
pubmed: 28713349
BMC Med Res Methodol. 2012 Aug 03;12:115
pubmed: 22862851
Appl Environ Microbiol. 2021 May 11;87(11):
pubmed: 33741632
Diabetes Care. 2013 Nov;36(11):3627-32
pubmed: 23835694
Signal Transduct Target Ther. 2022 Apr 23;7(1):135
pubmed: 35461318
Front Microbiol. 2020 Jun 09;11:1065
pubmed: 32582063
J Biosci. 2012 Sep;37(4):647-57
pubmed: 22922190
J Obes. 2012;2012:879151
pubmed: 22315672
Int J Environ Res Public Health. 2019 Oct 23;16(21):
pubmed: 31652705
Arch Med Sci. 2011 Jun;7(3):501-7
pubmed: 22295035
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Diabetes Care. 2011 Aug;34(8):1809-15
pubmed: 21636801
PLoS One. 2014 Jan 08;9(1):e84689
pubmed: 24416266
Antioxidants (Basel). 2021 May 20;10(5):
pubmed: 34065281
Rev Endocr Metab Disord. 2019 Dec;20(4):461-472
pubmed: 31707624
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
Mediators Inflamm. 2010;2010:
pubmed: 20706689
PLoS One. 2010 Feb 05;5(2):e9085
pubmed: 20140211
Front Cell Infect Microbiol. 2021 Nov 17;11:747816
pubmed: 34869058
J Formos Med Assoc. 2019 Mar;118 Suppl 1:S3-S9
pubmed: 30057153

Auteurs

Cristina Politi (C)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Marco Mobrici (M)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Rosa Maria Parlongo (RM)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Belinda Spoto (B)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Giovanni Tripepi (G)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Patrizia Pizzini (P)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Sebastiano Cutrupi (S)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Daniele Franco (D)

Medilink S.r.l., Via Parma 36/A, Città Giardino, 96010 Melilli, SR, Italy.

Renato Tino (R)

Medilink S.r.l., Via Parma 36/A, Città Giardino, 96010 Melilli, SR, Italy.

Giuseppe Farruggio (G)

SB SETEC S.p.A., Via Benedetto Croce 11, Città Giardino, 96010 Melilli, SR, Italy.

Chiara Failla (C)

Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, ME, Italy.
Classical Linguistic Studies and Education Department, Kore University of Enna, 94100 Enna, EN, Italy.

Flavia Marino (F)

Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, ME, Italy.

Giovanni Pioggia (G)

Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, ME, Italy.

Alessandra Testa (A)

Institute of Clinical Physiology (IFC), National Research Council of Italy (CNR), 89124 Reggio Calabria, RC, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH